Michel Giunta
Participates in 1 Session
Sessions in which Michel Giunta participates
3:35 PM
3:35 PM
- Treatment switch from aflibercept to ranibizumab in Canadian DME patients in a real-world setting: the PRECISE study 237
- Speaker Michel Giunta |
- 3:35 PM - 3:43 PM | 8 minutes Part of: Retina I
- Paper Presentation | Présentation d'article